Funding for this research was provided by:
AstraZeneca (ERID-KSOPKR/47)
Article History
Received: 16 September 2020
Accepted: 21 October 2020
First Online: 29 October 2020
Ethics approval and consent to participate
: All patients gave written informed consent. This retrospective analysis is in compliance with the principles of the Declaration of Helsinki and its subsequent amendments. This retrospective analysis was approved by Institutional Review Board Committee and Institutional Ethics Committee of the Institute of Oncology Ljubljana, Slovenia (ERID-EK/172).
: Not applicable.
: The authors declare that they have no competing interests.